Global Closed Drug Transfer Systems  Market

Closed Drug Transfer Systems  Comprehensive Study by Type (Membrane-to-Membrane Systems, Needleless Systems), Application (Hospital, Oncology Centers & Clinics), Component (Closed Vial Access Devices, Closed Syringe Safety Devices, Closed Bag/Line Access Devices) Players and Region - Global Market Outlook to 2026

Closed Drug Transfer Systems  Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Closed Drug Transfer Systems  Market Scope?
Closed drug transfer systems are outlined as drug transfer devices that compel the transfer of environmental contaminants into the system and release the dangerous vapor concentrations outside the system. The system is employed to transfer hazardous medication from one receptacle to a different while not being exposed to outside atmosphere and to the one who is functioning on that. For instance, for preparing and administering therapy medication containing hazardous antineoplastic agents, there's a requirement to transfer drug from vial to syringe then from syringe to IV infusion bag. During every transfer there's an occasion for exposure to the hazardous drugs. To forestall such exposure, closed drug transfer systems are used as these exposures might result in serious health complications from skin irritation to birth defects and even some style of cancers. One among the studies demonstrates that nurses operating with cytotoxic drugs on regular basis have found a statistically higher rate of spontaneous abortion.

The Closed Drug Transfer Systems  market study is being classified by Type (Membrane-to-Membrane Systems and Needleless Systems), by Application (Hospital and Oncology Centers & Clinics) and major geographies with country level break-up.

Among all the available closed drug transfer systems, chemoclave is considered as the most efficient system on the basis of exposure percentage, cost-effectiveness and amount of bio-hazardous waste generation. The demand for the system is increasing due to the growing awareness about the healthcare products. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Closed Drug Transfer Systems  market throughout the predicted period.

B.Braun Medical, Inc. (United States), Becton Dickinson and Company (United States), iCU Medical, Inc (United States), EquaShield Medical (United States) and Carefusion Corporation (United States) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Closed Drug Transfer Systems  market by Type, Application and Region.

On the basis of geography, the market of Closed Drug Transfer Systems  has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Singapore, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Spain, Rest of Europe), MEA (Saudi Arabia, Turkey, Israel, United Arab Emirates, South Africa, Rest of Africa), North America (United States, Canada, Mexico).




Influencing Market Trend
  • Increasing Number of Oncology Drug Approvals

Market Drivers
  • Increasing Use of Closed System Transfer Devices to Combat the Harmful Effects of Cytotoxic or Antineoplastic Drugs
  • The Rising Prevalence of Cancer

Opportunities
  • New Products Innovations Are Also Helping the Market to Grow

Restraints
  • Unfavorable Reimbursement Policies

Challenges
  • The Bio-Hazardous Waste Generated by The Closed Drug Transfer Systems


Key Target Audience
Providers of Closed Drug Transfer Systems, Governmental and Regulatory bodies and End-Users

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Membrane-to-Membrane Systems
  • Needleless Systems
By Application
  • Hospital
  • Oncology Centers & Clinics
By Component
  • Closed Vial Access Devices
  • Closed Syringe Safety Devices
  • Closed Bag/Line Access Devices

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Spain
    • Rest of Europe
  • MEA
    • Saudi Arabia
    • Turkey
    • Israel
    • United Arab Emirates
    • South Africa
    • Rest of Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Use of Closed System Transfer Devices to Combat the Harmful Effects of Cytotoxic or Antineoplastic Drugs
      • 3.2.2. The Rising Prevalence of Cancer
    • 3.3. Market Challenges
      • 3.3.1. The Bio-Hazardous Waste Generated by The Closed Drug Transfer Systems
    • 3.4. Market Trends
      • 3.4.1. Increasing Number of Oncology Drug Approvals
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Closed Drug Transfer Systems , by Type, Application, Component and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Closed Drug Transfer Systems  (Value)
      • 5.2.1. Global Closed Drug Transfer Systems  by: Type (Value)
        • 5.2.1.1. Membrane-to-Membrane Systems
        • 5.2.1.2. Needleless Systems
      • 5.2.2. Global Closed Drug Transfer Systems  by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Oncology Centers & Clinics
      • 5.2.3. Global Closed Drug Transfer Systems  by: Component (Value)
        • 5.2.3.1. Closed Vial Access Devices
        • 5.2.3.2. Closed Syringe Safety Devices
        • 5.2.3.3. Closed Bag/Line Access Devices
      • 5.2.4. Global Closed Drug Transfer Systems  Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Singapore
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Spain
          • 5.2.4.3.7. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Saudi Arabia
          • 5.2.4.4.2. Turkey
          • 5.2.4.4.3. Israel
          • 5.2.4.4.4. United Arab Emirates
          • 5.2.4.4.5. South Africa
          • 5.2.4.4.6. Rest of Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Closed Drug Transfer Systems  (Price)
      • 5.3.1. Global Closed Drug Transfer Systems  by: Type (Price)
  • 6. Closed Drug Transfer Systems : Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. B.Braun Medical, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Becton Dickinson and Company (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. ICU Medical, Inc (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. EquaShield Medical (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Carefusion Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
  • 7. Global Closed Drug Transfer Systems  Sale, by Type, Application, Component and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Closed Drug Transfer Systems  (Value)
      • 7.2.1. Global Closed Drug Transfer Systems  by: Type (Value)
        • 7.2.1.1. Membrane-to-Membrane Systems
        • 7.2.1.2. Needleless Systems
      • 7.2.2. Global Closed Drug Transfer Systems  by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Oncology Centers & Clinics
      • 7.2.3. Global Closed Drug Transfer Systems  by: Component (Value)
        • 7.2.3.1. Closed Vial Access Devices
        • 7.2.3.2. Closed Syringe Safety Devices
        • 7.2.3.3. Closed Bag/Line Access Devices
      • 7.2.4. Global Closed Drug Transfer Systems  Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Singapore
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Spain
          • 7.2.4.3.7. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Saudi Arabia
          • 7.2.4.4.2. Turkey
          • 7.2.4.4.3. Israel
          • 7.2.4.4.4. United Arab Emirates
          • 7.2.4.4.5. South Africa
          • 7.2.4.4.6. Rest of Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Closed Drug Transfer Systems  (Price)
      • 7.3.1. Global Closed Drug Transfer Systems  by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Closed Drug Transfer Systems : by Type(USD Million)
  • Table 2. Closed Drug Transfer Systems  Membrane-to-Membrane Systems , by Region USD Million (2015-2020)
  • Table 3. Closed Drug Transfer Systems  Needleless Systems , by Region USD Million (2015-2020)
  • Table 4. Closed Drug Transfer Systems : by Application(USD Million)
  • Table 5. Closed Drug Transfer Systems  Hospital , by Region USD Million (2015-2020)
  • Table 6. Closed Drug Transfer Systems  Oncology Centers & Clinics , by Region USD Million (2015-2020)
  • Table 7. Closed Drug Transfer Systems : by Component(USD Million)
  • Table 8. Closed Drug Transfer Systems  Closed Vial Access Devices , by Region USD Million (2015-2020)
  • Table 9. Closed Drug Transfer Systems  Closed Syringe Safety Devices , by Region USD Million (2015-2020)
  • Table 10. Closed Drug Transfer Systems  Closed Bag/Line Access Devices , by Region USD Million (2015-2020)
  • Table 11. South America Closed Drug Transfer Systems , by Country USD Million (2015-2020)
  • Table 12. South America Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 13. South America Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 14. South America Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 15. Brazil Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 16. Brazil Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 17. Brazil Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 18. Argentina Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 19. Argentina Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 20. Argentina Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 21. Rest of South America Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 22. Rest of South America Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 23. Rest of South America Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 24. Asia Pacific Closed Drug Transfer Systems , by Country USD Million (2015-2020)
  • Table 25. Asia Pacific Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 26. Asia Pacific Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 27. Asia Pacific Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 28. China Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 29. China Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 30. China Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 31. Japan Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 32. Japan Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 33. Japan Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 34. India Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 35. India Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 36. India Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 37. South Korea Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 38. South Korea Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 39. South Korea Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 40. Singapore Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 41. Singapore Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 42. Singapore Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 43. Australia Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 44. Australia Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 45. Australia Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 46. Rest of Asia-Pacific Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 47. Rest of Asia-Pacific Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 48. Rest of Asia-Pacific Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 49. Europe Closed Drug Transfer Systems , by Country USD Million (2015-2020)
  • Table 50. Europe Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 51. Europe Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 52. Europe Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 53. Germany Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 54. Germany Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 55. Germany Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 56. France Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 57. France Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 58. France Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 59. Italy Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 60. Italy Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 61. Italy Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 62. United Kingdom Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 63. United Kingdom Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 64. United Kingdom Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 65. Netherlands Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 66. Netherlands Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 67. Netherlands Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 68. Spain Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 69. Spain Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 70. Spain Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 71. Rest of Europe Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 72. Rest of Europe Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 73. Rest of Europe Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 74. MEA Closed Drug Transfer Systems , by Country USD Million (2015-2020)
  • Table 75. MEA Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 76. MEA Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 77. MEA Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 78. Saudi Arabia Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 79. Saudi Arabia Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 80. Saudi Arabia Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 81. Turkey Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 82. Turkey Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 83. Turkey Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 84. Israel Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 85. Israel Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 86. Israel Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 87. United Arab Emirates Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 88. United Arab Emirates Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 89. United Arab Emirates Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 90. South Africa Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 91. South Africa Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 92. South Africa Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 93. Rest of Africa Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 94. Rest of Africa Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 95. Rest of Africa Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 96. North America Closed Drug Transfer Systems , by Country USD Million (2015-2020)
  • Table 97. North America Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 98. North America Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 99. North America Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 100. United States Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 101. United States Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 102. United States Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 103. Canada Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 104. Canada Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 105. Canada Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 106. Mexico Closed Drug Transfer Systems , by Type USD Million (2015-2020)
  • Table 107. Mexico Closed Drug Transfer Systems , by Application USD Million (2015-2020)
  • Table 108. Mexico Closed Drug Transfer Systems , by Component USD Million (2015-2020)
  • Table 109. Closed Drug Transfer Systems : by Type(USD/Units)
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Company Basic Information, Sales Area and Its Competitors
  • Table 115. Closed Drug Transfer Systems : by Type(USD Million)
  • Table 116. Closed Drug Transfer Systems  Membrane-to-Membrane Systems , by Region USD Million (2021-2026)
  • Table 117. Closed Drug Transfer Systems  Needleless Systems , by Region USD Million (2021-2026)
  • Table 118. Closed Drug Transfer Systems : by Application(USD Million)
  • Table 119. Closed Drug Transfer Systems  Hospital , by Region USD Million (2021-2026)
  • Table 120. Closed Drug Transfer Systems  Oncology Centers & Clinics , by Region USD Million (2021-2026)
  • Table 121. Closed Drug Transfer Systems : by Component(USD Million)
  • Table 122. Closed Drug Transfer Systems  Closed Vial Access Devices , by Region USD Million (2021-2026)
  • Table 123. Closed Drug Transfer Systems  Closed Syringe Safety Devices , by Region USD Million (2021-2026)
  • Table 124. Closed Drug Transfer Systems  Closed Bag/Line Access Devices , by Region USD Million (2021-2026)
  • Table 125. South America Closed Drug Transfer Systems , by Country USD Million (2021-2026)
  • Table 126. South America Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 127. South America Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 128. South America Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 129. Brazil Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 130. Brazil Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 131. Brazil Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 132. Argentina Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 133. Argentina Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 134. Argentina Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 135. Rest of South America Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 136. Rest of South America Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 137. Rest of South America Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 138. Asia Pacific Closed Drug Transfer Systems , by Country USD Million (2021-2026)
  • Table 139. Asia Pacific Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 140. Asia Pacific Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 141. Asia Pacific Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 142. China Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 143. China Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 144. China Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 145. Japan Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 146. Japan Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 147. Japan Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 148. India Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 149. India Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 150. India Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 151. South Korea Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 152. South Korea Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 153. South Korea Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 154. Singapore Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 155. Singapore Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 156. Singapore Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 157. Australia Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 158. Australia Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 159. Australia Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 160. Rest of Asia-Pacific Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 161. Rest of Asia-Pacific Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 162. Rest of Asia-Pacific Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 163. Europe Closed Drug Transfer Systems , by Country USD Million (2021-2026)
  • Table 164. Europe Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 165. Europe Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 166. Europe Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 167. Germany Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 168. Germany Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 169. Germany Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 170. France Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 171. France Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 172. France Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 173. Italy Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 174. Italy Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 175. Italy Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 176. United Kingdom Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 177. United Kingdom Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 178. United Kingdom Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 179. Netherlands Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 180. Netherlands Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 181. Netherlands Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 182. Spain Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 183. Spain Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 184. Spain Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 185. Rest of Europe Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 186. Rest of Europe Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 187. Rest of Europe Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 188. MEA Closed Drug Transfer Systems , by Country USD Million (2021-2026)
  • Table 189. MEA Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 190. MEA Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 191. MEA Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 192. Saudi Arabia Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 193. Saudi Arabia Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 194. Saudi Arabia Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 195. Turkey Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 196. Turkey Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 197. Turkey Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 198. Israel Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 199. Israel Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 200. Israel Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 201. United Arab Emirates Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 202. United Arab Emirates Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 203. United Arab Emirates Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 204. South Africa Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 205. South Africa Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 206. South Africa Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 207. Rest of Africa Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 208. Rest of Africa Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 209. Rest of Africa Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 210. North America Closed Drug Transfer Systems , by Country USD Million (2021-2026)
  • Table 211. North America Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 212. North America Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 213. North America Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 214. United States Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 215. United States Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 216. United States Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 217. Canada Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 218. Canada Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 219. Canada Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 220. Mexico Closed Drug Transfer Systems , by Type USD Million (2021-2026)
  • Table 221. Mexico Closed Drug Transfer Systems , by Application USD Million (2021-2026)
  • Table 222. Mexico Closed Drug Transfer Systems , by Component USD Million (2021-2026)
  • Table 223. Closed Drug Transfer Systems : by Type(USD/Units)
  • Table 224. Research Programs/Design for This Report
  • Table 225. Key Data Information from Secondary Sources
  • Table 226. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Closed Drug Transfer Systems : by Type USD Million (2015-2020)
  • Figure 5. Global Closed Drug Transfer Systems : by Application USD Million (2015-2020)
  • Figure 6. Global Closed Drug Transfer Systems : by Component USD Million (2015-2020)
  • Figure 7. South America Closed Drug Transfer Systems  Share (%), by Country
  • Figure 8. Asia Pacific Closed Drug Transfer Systems  Share (%), by Country
  • Figure 9. Europe Closed Drug Transfer Systems  Share (%), by Country
  • Figure 10. MEA Closed Drug Transfer Systems  Share (%), by Country
  • Figure 11. North America Closed Drug Transfer Systems  Share (%), by Country
  • Figure 12. Global Closed Drug Transfer Systems : by Type USD/Units (2015-2020)
  • Figure 13. Global Closed Drug Transfer Systems  share by Players 2020 (%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. B.Braun Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 16. B.Braun Medical, Inc. (United States) Revenue: by Geography 2020
  • Figure 17. Becton Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 18. Becton Dickinson and Company (United States) Revenue: by Geography 2020
  • Figure 19. ICU Medical, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 20. ICU Medical, Inc (United States) Revenue: by Geography 2020
  • Figure 21. EquaShield Medical (United States) Revenue, Net Income and Gross profit
  • Figure 22. EquaShield Medical (United States) Revenue: by Geography 2020
  • Figure 23. Carefusion Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 24. Carefusion Corporation (United States) Revenue: by Geography 2020
  • Figure 25. Global Closed Drug Transfer Systems : by Type USD Million (2021-2026)
  • Figure 26. Global Closed Drug Transfer Systems : by Application USD Million (2021-2026)
  • Figure 27. Global Closed Drug Transfer Systems : by Component USD Million (2021-2026)
  • Figure 28. South America Closed Drug Transfer Systems  Share (%), by Country
  • Figure 29. Asia Pacific Closed Drug Transfer Systems  Share (%), by Country
  • Figure 30. Europe Closed Drug Transfer Systems  Share (%), by Country
  • Figure 31. MEA Closed Drug Transfer Systems  Share (%), by Country
  • Figure 32. North America Closed Drug Transfer Systems  Share (%), by Country
  • Figure 33. Global Closed Drug Transfer Systems : by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • B.Braun Medical, Inc. (United States)
  • Becton Dickinson and Company (United States)
  • iCU Medical, Inc (United States)
  • EquaShield Medical (United States)
  • Carefusion Corporation (United States)
Select User Access Type

Key Highlights of Report


Jun 2021 202 Pages 50 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Closed Drug Transfer Systems  Market Quantitative research analysis
Global Closed Drug Transfer Systems  Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Global Closed Drug Transfer Systems  market is expected to see a growth of % during projected year 2020 to 2026.
The prominent players of Global Closed Drug Transfer Systems  market are B.Braun Medical, Inc. (United States), Becton Dickinson and Company (United States), iCU Medical, Inc (United States), EquaShield Medical (United States) and Carefusion Corporation (United States), to name a few.
In this highly competitive & fast evolving Closed Drug Transfer Systems  industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.

Know More About Global Closed Drug Transfer Systems  Market Report?

Have a Query? Click Here

Other Related Reports

Airport Baggage Tracking Systems Comprehensive Study by Application (Narcotic Detection, Metal & Contraband Detection, Explosive Detection, Others), Technology (Smart Tags, Radio Frequency Identifica...
$ 3750
Application Metrics And Monitoring Tools Comprehensive Study by Application (Experience Monitoring, Application Runtime Architecture Discovery and Modeling, User-Defined Transaction, Application Comp...
$ 3750
Advanced Mobile UX Design Services Comprehensive Study by Type (Online Service, Offline Service), Device Type (Smartphone {Android, Iphone, Others}, Wearables {Smart Watches, and Smart Bands}, Tablet...
$ 3650
MEA Enterprise Software Comprehensive Study by Application (Email Marketing, Enterprise Resource Planning (ERP), Business Intelligence (BI), Supply Chain Management (SCM), Payment Processing, Others)...
$ 3750
Software Assurance Comprehensive Study by Application (Banking, Financial Services and Insurance (BFSI), Retail And Consumer Goods, Healthcare, IT And Telecommunications, Transportation And Logistics...
$ 3750
Bitcoin Mining Servers Comprehensive Study by Type (Hardware, Software), Components (Hardware (ASIC, FPGA, CPU, GPU), Software), Services (Energy-efficient Mining Solutions, Enterprise-grade Bitcoin ...
$ 3650